Eam Global Investors LLC Ardelyx, Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$5.37 - $8.11 $1.69 Million - $2.55 Million
-314,295 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$4.35 - $8.79 $172,329 - $348,224
39,616 Added 14.42%
314,295 $1.79 Million
Q3 2019

Nov 13, 2019
BUY
$2.15 - $6.28 $590,559 - $1.72 Million
274,679 New
274,679 $1.29 Million

Others Institutions Holding ARDX

# of Institutions
218
Shares Held
142M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $863M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email